Author's posts
This Startup Wants To Treat Mild Cases Of Covid With LED Lights
Medical device company EmitBio is testing a device that uses precise light frequencies it claims can keep the coronavirus at bay.
Pfizer Received Full FDA Approval For Its Covid Vaccine: Here’s What’s Next
On Monday, the Food and Drug Administration granted full approval for Pfzer/BioNTech’s Covid-19 vaccine, now marketed under the name Comirnaty, for everyone aged 16 and up.
50 Over 50: How This Iranian Immigrant’s Vision Could Revolutionize Cancer Treatment
Helen Sabzevari has researched cancer her entire life. Now her company, Precigen, is trying to transform the way it’s treated.
This Company Aims To Bring Down The Cost Of Your Medicine With Price Transparency
Capital Rx’s new prescription drug card aims to compete with the likes of GoodRx.
Johnson & Johnson Executives Say Administration Of The Company’s Covid-19 Vaccine Will Resume Soon
Regulators in the EU and US meet this week to determine whether to resume administering the vaccine after reports of an extremely rare blood clotting side effect.
How The Johnson & Johnson Vaccine Pause Might Slow Down The Global Covid-19 Response
Richer countries have the luxury of picking and choosing between vaccine options, but their regulatory decisions may make it harder for poorer countries to fight the pandemic.
Why The Government Can Easily Hit Pause On The J&J Vaccine
While the chance of a blood clot from the J&J vaccine is astronomically low and vaccinating as many people as possible is a paramount goal, the government felt confident it could afford to stop its use.
Federal Grand Jury Indicts uBiome Cofounders On Criminal Fraud Charges
On Thursday, a Federal grand jury indicted biotech startup uBiome’s cofounders Jessica Richman and Michael Apte with multiple charges related to defrauding insurance companies and investors.
SEC Charges Microbiome Startup uBiome’s Cofounders With Defrauding Investors For $60 Million
Jessica Richman and Zachary Apte were charged Thursday for failing to disclose significant issues related to the company’s insurance billing practices.
Politics, Not Science, May Be Behind Suspensions Of AstraZeneca’s Covid Vaccine
Multiple experts say that the drug company’s vaccine is being unfairly targeted by EU countries, hindering plans to roll it out worldwide at a critical time.
